CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Lidia Fonseca

Executive VP and Chief Digital & Technology Officer, Pfizer

Search every verified Lidia Fonseca interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Lidia Fonseca, Executive Vice President and Chief Digital & Technology Officer at Pfizer, has continued to lead the company’s digital and AI strategy, emphasizing the need to reinvent workflows rather than make incremental improvements. In a series of podcast appearances and keynote speeches throughout 2025, she stated that Pfizer is focused on adopting an “AI-first mindset” and measuring the return on AI investments through business metrics such as revenue, cost savings, and time to market. She noted that Pfizer has achieved over a billion dollars in incremental business value from AI programs and is on track to reach two billion by 2026. Fonseca also highlighted the launch of the AI Academy in 2024 to increase AI fluency across the organization and the creation of tools such as Ethicara, which uses AI to identify bias, and Health Answers by Pfizer, a generative AI app that provides health information from trusted third-party sources. Fonseca has also discussed the importance of equity and inclusion in AI adoption, stating that “the best ideas for applications of AI are going to come from the people most impacted by them.” She has advocated for a new leadership formula that combines IQ, EQ, and “TQ” (technology quotient), and has stressed that leaders must model curiosity and vulnerability when adopting new technologies. In conversations with figures such as Accenture CEO Julie Sweet and Thrive Global CEO Arianna Huffington, Fonseca argued that successful AI adoption depends on coordinated investment in people’s skills and that human wisdom, empathy, and resilience remain essential as technology evolves. She has also pointed to Pfizer’s ambition to apply the lessons from its COVID-19 vaccine development to the fight against cancer, stating that “time is life” for patients.

Recent appearances

Other executives at Pfizer

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →